AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06737796 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: syringe feeding
Description: feeding method
Study NCT06738706 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: intermittent hypoxia-hyperoxia treatment
Description: The intermittent hypoxia-hyperoxia training refers to 4 cycles of 10-minute hypoxia inhalation interspersed with 20-minute hyperoxia, which is performed once daily for 14 days within 2 to 3 weeks.
Study NCT05347017 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Alveolar ridge preservation using autogenous bone block graft
Description: Atraumatic extraction of non restorable tooth, then the autogenous bone block graft will be harvested from the maxillary tuberosity and reshaped and inserted into the socket
Study NCT06741085 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: osimertinib
Description: oral EGFR-TKI
Study NCT06741085 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: osimertinib
Description: oral EGFR-TKI
Study NCT06741085 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic radiosurgery (SRS)
Description: 0-20mm-18Gy x 1, 21Gy x 1 ,9Gy x 3~20mm or larger- 9Gy x 3, 6Gy x 5, 5Gy x 5
Study NCT06740799 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quizartinib
Description: Participants will receive a single oral dose of 30 mg
Study NCT06737718 — intervention group
Intervention type: OTHER
Intervention: Eye tracking
Description: The eye-tracking session will take place in the Pediatric Radiology department of Necker Hospital. The child will be seated in front of a computer screen. Films and images with social and/or non-social content will be shown to the children. The session will be unique, will last approximately 15 minutes and will not involve any constraints for the child.~Eye tracking allows to measure where and how a person looks. An infrared light is emitted towards the subject's eye. It is reflected there and a camera records the reflections generated, allowing a real-time calculation of the position of the gaze. The technique is harmless and non-invasive.
Study NCT06737718 — intervention group
Intervention type: OTHER
Intervention: Data collection from patients' medical files
Description: Data collection from patients' medical files:~* Brain imaging data if this examination was carried out as part of the patient's care,~* Angelman syndrome genotypes.
Study NCT06740526 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sibeprenlimab
Description: Sibeprelimab SC (Period 1)~Sibeprelimab SC (Period 2)
Study NCT06736678 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Oral Immunonutrition
Description: Patients receive enteral immunonutrition, Oral Impact® Nestle for 6 weeks from one week before radiotherapy;
Study NCT06736912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IN-114199 2.5mg or placebo
Description: IN-114199 2.5mg or placebo (1 Tablet, QD)
Study NCT05318833 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS7415
Description: Drug: HRS7415
Study NCT04886245 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video sequences
Description: videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound \[o\], the labial protrusion on the sound \[pu\] and the wide smile uncovering the teeth.~Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.
Study NCT04886245 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Video sequences
Description: videos will be made of each participant, during the realization of 5 movements that are the simple closure of the eyelids, the forced closure of the eyelids, the labial protrusion on the sound \[o\], the labial protrusion on the sound \[pu\] and the wide smile uncovering the teeth.~Then, a video sequence will be realized thanks to the dedicated software Tobii Pro Lab®.
Study NCT04918472 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: MCCE
Description: Mangetically controlled capsule endoscopy will be performed
Study NCT04869852 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Food
Description: 85g mango, 4x/week
Study NCT04964583 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Hydroxychloroquine with Azithromycin
Description: Fixed combination of Hydroxychloroquine with Azithromycin 200 mg / 250 mg one tablet every 12 hours for five days and continue with Hydroxychloroquine 200 mg one tablet every 12 hours for 5 more days.
Study NCT04964583 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine with Azithromycin
Description: Fixed combination of Hydroxychloroquine with Azithromycin 200 mg / 250 mg one tablet every 12 hours for five days and continue with Hydroxychloroquine 200 mg one tablet every 12 hours for 5 more days.
Study NCT04964583 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Hydroxychloroquine with Azithromycin
Description: Fixed combination of Hydroxychloroquine with Azithromycin 200 mg / 250 mg one tablet every 12 hours for five days and continue with Hydroxychloroquine 200 mg one tablet every 12 hours for 5 more days.
Study NCT05707949 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atogepant
Description: Oral Tablet
Study NCT05730114 — intervention group
Intervention type: DRUG
Intervention: Antiplatelet Drug
Description: anti-P2Y12 oral agent administered during primary percutaneous coronary intervention.
Study NCT05526365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reduced Idea Density
Description: Question idea density reduced (ratio of propositions to total words used).
Study NCT05395364 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention program BeE-school
Description: The intervention program will be co-developed and directed to school professionals. It will be based on the promotion of health literacy and lifestyles.
Study NCT06305442 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Microbiota-Directed Food
Description: MDF is a microbiota directed food for malnourished children aged 6 months and above. It is in sachet form. The sachet contains 92 gm of supplements and provides approximately 506 kcal.
Study NCT06305442 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Ready-to-Use Supplementary Food
Description: RUSF is standard ready-to-use supplementary food for MAM children aged 6 months and above.
Study NCT05152199 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Cystoscopy - with use of obturator sheath
Description: The intervention arm will include the use of the obturator sheath upon entry into the urethra during rigid cystoscopy.
Study NCT05152199 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Cystoscopy - without use of obturator sheath
Description: The intervention arm will not include the use of the obturator sheath upon entry into the urethra during rigid cystoscopy, but will consist of using the telescope under direct visualization.
Study NCT05132790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-1316 at a dose 20mg/kg q3w
Description: Combination of SBRT and SHR1316, followed by SHR1316 plus nab-paclitaxel and carboplatin or cisplatin
Study NCT05132790 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR6390 at a dose of 150mg orally, daily
Description: SHR6390 plus exemestane with/without ovarian function suppression/ablation (OFS) after SBRT
Study NCT05132790 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: SBRT
Description: radiation therapy for breast cance before surgery.
Study NCT06613035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Selinexor: 60 mg/day from days -9 to -5.
Study NCT06613035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melphalan
Description: Selinexor: 60 mg/day from days -9 to -5.
Study NCT06613035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Intravenous Busulfan
Description: 3.2 mg/kg on days
Study NCT06613035 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: 30 mg/m² on days
Study NCT06668103 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABSK043 in combination with Firmonertinib
Description: Two potential dose levels ：400 mg twice daily （BID） and 800 mg BID) of ABSK043 are prespecified and firmonertinib will be administered orally at a fixed dose of 80 mg once daily (QD).~Patients in dose escalation cohort will receive the ABSK043, 400 mg BID and firmonertinib 80 mg QD as the starting dose for the combination therapy.~Patients in dose confirmation cohort and dose expansion cohort will receive the recommended dose in dose escalation cohort and be evaluated for safety and preliminary anti-tumor activity of the combination therapy.~After Cycle 1, patients will continue to receive combination therapy every 21 days until disease progression, death, loss to follow-up, withdrawal of consent, intolerable toxicity, investigator decision to discontinue treatment, or end of the study.
Study NCT05690763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: XP-endo Finisher to use irrigation activation
Description: XPF : The canals were flushed with 2.5 mL 2.5% NaOCl for 30 s and activated by a XPF instrument that was placed in the canal to 1 mm short of the WL and powered by the motor at 800 rpm (1 N-cm torque) for 30 s according to the manufacturer's instructions. Then the canals were rinsed with 2.5 mL of 2.5% NaOCl, followed by activation of the substance with the XPF instrument for 30 seconds, the same way as above. A new XP-endo Finisher file was used for each canal.
Study NCT05690763 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EndoActivator to use irrigation activation
Description: The root canals were irrigated with 2.5 mL of 2.5% NaOCl for 30 s, followed by sonic activation of this solution with EndoActivator red tip size #25/0.04, inserted into the root canal 1 mm short of the WL, at 10,000 cpm/min. for 30 seconds. The EA polymer tip moved vertically from apical to coronal part of the canal during activation.
Study NCT05194943 — intervention group
Intervention type: PROCEDURE
Intervention: revisional bariatric surgical procedures
Description: Any procedure performed as a second or third after an initial, primary bariatric surgery, performed due to complications or due to scarce results in term of weight loss and comorbidities improvement
Study NCT06385925 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TSN1611
Description: TSN1611 will be administered at the assigned dose level, orally, until disease progression or intolerable toxicity.
Study NCT06417034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Game Software
Description: The software is interfaced with a modified version of Frets on Fire (FOF)-an open source computer game similar to Guitar Hero.
Study NCT06417034 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Game Software
Description: The software is interfaced with a modified version of Frets on Fire (FOF)-an open source computer game similar to Guitar Hero.
Study NCT06485583 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Constraint-induced movement therapy
Description: is a rehabilitation technique used to improve motor function in people who have had a stroke or other neurological conditions. CIMT restricts the use of the unaffected limb, typically with a mitt or sling, to encourage the use of the affected limb.
Study NCT06485583 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Neurodevelopmental Treatment
Description: Therapy, is a rehabilitation approach used to address movement and motor control deficits in people with neurological illnesses such as stroke, cerebral palsy, or traumatic brain injury.
Study NCT05382039 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Nerve Stimulation
Description: High frequency sensory transcutaneous electrical nerve stimulation
Study NCT06060483 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: CGM
Description: Wear CGM continuously and manage patients based on CGM. The treatment goals are TIR>70%, TBR\<4%, TAR\<25%, and HbA1c\<7.0%. After the treatment reaches the standard, CGM is worn every six months.
Study NCT06736912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IN-114199 10mg or placebo
Description: IN-114199 10mg or placebo (1 Tablet, QD)
Study NCT06547567 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: In addition to receiving the same health education intervention as the control group, the children and adolescents in the intervention group will undergo a group-based motivational interviewing intervention. This will be conducted by a professional team that has been trained and is qualified in motivational interviewing. The intervention will embody the spirit of motivational interviewing and the stages of group motivation development, primarily including: introductory tasks, exploratory tasks, expansion tasks, and action planning tasks.
Study NCT06456606 — intervention group
Intervention type: PROCEDURE
Intervention: before prone position
Description: It was evaluated with transesophageal echocardiography
Study NCT06456606 — intervention group
Intervention type: PROCEDURE
Intervention: the first hour of prone position
Description: It was evaluated with transesophageal echocardiography
Study NCT06456606 — intervention group
Intervention type: PROCEDURE
Intervention: the first hour of returning to the supine position
Description: It was evaluated with transesophageal echocardiography
Study NCT06736912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IN-114199 20mg or placebo
Description: IN-114199 10mg or placebo (2 Tablets, QD)
Study NCT06736912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IN-114199 40mg or placebo
Description: IN-114199 10mg or placebo (4 Tablets, QD)
Study NCT06736912 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IN-114199 5mg or placebo
Description: IN-114199 2.5mg or placebo (2 Tablets, QD)
Study NCT06737211 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Peripheral Parenteral Nutrition
Description: 2000 mL of peripheral parenteral nutrition with electrolytes (20 mL 7.45% KCl, 10 mL 20% MgSO4 and 20 mL 8.7% Na3PO4) will be administered via a peripheral venous catheter with a rhythm of 80cc/h from the time they will leave the operation room and will be transferred to the ward or the critical care unit (CCU) until the 5th postoperative day
Study NCT05282836 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Hydrogen Oxygen Generator with Nebulizer
Description: Patients in treatment group inhaled H2-O2 (66% hydrogen; 33% oxygen) at 3 L/min via nasal cannula by using the Hydrogen/Oxygen Generator (model AMS-H-03, Shanghai Asclepius Meditech Co., Ltd., China) during a 7-day stay in the intensive care unit.
Study NCT04927923 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hope-focused motivational interview
Description: The eight-week hope-focused motivational interview will be applied to each individual individually during dialysis treatment. Within the scope of the study, a hope tree will be created for each individual together with the patients to be used in the evaluation process of the interview sessions. Through the hope tree, it is aimed for the individual to set goals, to discover the obstacles and solutions in achieving these goals.
Study NCT04965337 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ASC42
Description: ASC42 tablet administered orally
Study NCT04965337 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Matching placebo administered orally
Study NCT06452290 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: brain 18F-FDG PET-CT
Description: PET scanner, Philips VEREOS PET/CT scanner. Three Philips VEREOS digital PET/CT scanners are installed in the nuclear medicine department.
Study NCT05616598 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sofosbuvir +daclatasvir+ simeprevir+Ribavirin
Description: Oral daily dose of Sofosbuvir +daclatasvir + simeprevir+ Ribavirin for 3 months
Study NCT06442696 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Health Education: Healthy Choices Program
Description: Six session for students and school personel
Study NCT05332678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SLS-005 - Once Weekly
Description: Please see Arm description.
Study NCT05332678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SLS-005 - Twice Weekly
Description: Please see Arm description.
Study NCT05317676 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Palmitoylethanolamide
Description: 2-month supply of PEA will be given upon discharge. 300mg will be taken twice a day in conjunction with discharge medications (opioid and NSAIDs).
Study NCT05317676 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 2-month supply of placebo will be given upon discharge. Placebo will taken twice a day in conjunction with discharge medications (opioid and NSAIDs).
Study NCT05599386 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Preoperative test
Description: Patients are subject to quantitative sensory testing, questionnaires, and biomarker analysis prior to surgery.
Study NCT05558436 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Genome-wide methylation profiling
Description: Detection for colorectal tumor-specific ctDNA methylation biomarkers
Study NCT04456244 — intervention group
Intervention type: OTHER
Intervention: Evaluation of the static posture
Description: Photographing from the back, front and side with ADIBAS posturography in standing position
Study NCT05953831 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CDR132L
Description: CDR132L is a synthetic antisense oligonucleotide (ASO) and a selective inhibitor of microRNA-132-3p (miR-132). miR-132 in cardiomyocytes is a central switch affecting the expression of genes that are crucially involved in maladaptive cardiac remodeling, transformation, and pathological cardiac growth (hypertrophy), contributing to adverse cardiac remodeling and heart failure (HF).1-5 Aberrant expression of miR-132 in cardiac cells is causally associated with cardiac remodeling and HF progression.
Study NCT05953831 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo to CDR132L
Study NCT04915131 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Bloomlife MFM-Pro
Description: Bloomlife MFM-Pro is a non-invasive, wireless, external monitoring system used to measure fetal heart rate and maternal heart rate on pregnant women with a singleton pregnancy.~The system acquires biopotential signals from abdominal surface electrodes.
Study NCT04722536 — intervention group
Intervention type: PROCEDURE
Intervention: Cervico-isthmic cerclage
Description: There is no intervention in this study. It's an observational retrospective study, before/after.
Study NCT05762952 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10mg Tab
Description: Once daily oral dapagliflozin 10mg
Study NCT05762952 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules formulated by pharmacy to be indistinguishable from active drug
Study NCT05566392 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Brain MRI
Description: Brain MRI including diffusion spectrum image, and functional MRI Interview with questionnaires for neuropsychiatric evaluation Near infrared spectroscopy and resting-state connectivity evaluation
Study NCT04952701 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Control lenses
Description: Control Multifocal lenses
Study NCT04952701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Control lenses
Description: Control Multifocal lenses
Study NCT04952701 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Test lenses
Description: Test Multifocal lenses
Study NCT04952701 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Test lenses
Description: Test Multifocal lenses
Study NCT06311643 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Postpartum back massage in study group
Description: Effleurage massage from shoulders toward lower back
Study NCT05297344 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: direct pulp capping
Description: direct pulp capping
Study NCT05297344 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: pulpotomy
Description: pulpotomy
Study NCT04919070 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Connect for Caregivers
Description: The intervention being studied is a single session guided behavioral intervention to improve social connectedness in caregivers of individuals with ADRD. The intervention, Connect for Caregivers, provides psychoeducation on the importance of social connectedness for health and well-being, includes a card-sort process to identify and prioritize barriers to connectedness, and provides personalized resources and strategies for caregivers to use to increase their social connectedness.
Study NCT05350488 — intervention group
Intervention type: OTHER
Intervention: Informational Interview
Description: Interview topics will fall in the broad categories of assessing medical knowledge and understanding of stroke, knowledge of medical and community resources, understanding and experience of post-stroke rehabilitation barriers faced upon reintegrating back home and ability to continue management of stroke diagnosis and suggestions for improvement.
Study NCT05350488 — intervention group
Intervention type: OTHER
Intervention: Focus Group
Description: Focus group topics will fall into the same broad categories as the informational interviews, however will be asked from a caregiver's perspective